These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31249971)

  • 1. Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism.
    Iñurrieta A; Pedrajas JM; Núñez MJ; López-Jiménez L; Velo-García A; García JC; Lecumberri R; Jiménez D; Pons I; Monreal M;
    TH Open; 2018 Oct; 2(4):e428-e436. PubMed ID: 31249971
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
    Farge D; Trujillo-Santos J; Debourdeau P; Bura-Riviere A; Rodriguez-Beltrán EM; Nieto JA; Peris ML; Zeltser D; Mazzolai L; Hij A; Monreal M;
    Medicine (Baltimore); 2015 Aug; 94(32):e1235. PubMed ID: 26266353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism.
    Gabara C; Aibar J; Nishimoto Y; Yamashita Y; Prandoni P; Barnes GD; Bikdeli B; Jiménez D; Demelo-Rodríguez P; Peris ML; Nguyen ST; Monreal M;
    J Thromb Haemost; 2024 May; ():. PubMed ID: 38762019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous Thromboembolism: Validation Study from RIETE Registry.
    Siniscalchi C; Suriñach JM; Visonà A; Fernández-Reyes JL; Gómez-Cuervo C; Verhamme P; Marchena PJ; Farge-Bancel D; Moisés J; Monreal M;
    TH Open; 2020 Jul; 4(3):e236-e244. PubMed ID: 32964178
    [No Abstract]   [Full Text] [Related]  

  • 5. Sex differences in patients receiving anticoagulant therapy for venous thromboembolism.
    Blanco-Molina A; Enea I; Gadelha T; Tufano A; Bura-Riviere A; Di Micco P; Bounameaux H; González J; Villalta J; Monreal M;
    Medicine (Baltimore); 2014 Oct; 93(17):309-317. PubMed ID: 25398066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism.
    Ruiz-Artacho P; Trujillo-Santos J; López-Jiménez L; Font C; Díaz-Pedroche MDC; Sánchez Muñoz-Torrero JF; Peris ML; Skride A; Maestre A; Monreal M;
    TH Open; 2018 Apr; 2(2):e210-e217. PubMed ID: 31249944
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry.
    Riera-Mestre A; Mora-Luján JM; Trujillo-Santos J; Del Toro J; Nieto JA; Pedrajas JM; López-Reyes R; Soler S; Ballaz A; Cerdà P; Monreal M;
    Orphanet J Rare Dis; 2019 Aug; 14(1):196. PubMed ID: 31399146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance and Outcome in Patients with Asymptomatic Versus Symptomatic Subsegmental Pulmonary Embolism.
    Rodríguez-Cobo A; Fernández-Capitán C; Tung-Chen Y; Salgueiro-Origlia G; Ballaz A; Bortoluzzi C; Sarlon-Bartoli G; Pesce ML; Najib D; Monreal M; The Riete Investigators
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.
    Madridano O; del Toro J; Lorenzo A; Martín M; Gómez Cerezo J; Hernández L; Prandoni P; Monreal M;
    J Vasc Surg Venous Lymphat Disord; 2015 Apr; 3(2):135-41.e1. PubMed ID: 26993830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation and venous thromboembolism in patients aged 90 years and older: Data from the RIETE registry.
    Lafaie L; Poenou G; Hanon O; López-Jiménez L; Nieto JA; Lorenzo A; Porras JA; Lumbierres M; Bertoletti L; Monreal M;
    J Am Geriatr Soc; 2024 Jan; 72(1):113-125. PubMed ID: 37814983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
    Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
    Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
    Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
    Tzoran I; Papadakis E; Brenner B; Valle R; López-Jiménez L; García-Bragado F; Riera-Mestre A; Villalobos A; Quintavalla R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S11-S15. PubMed ID: 28262227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis.
    Baumann Kreuziger L; Cote L; Verhamme P; Greenberg S; Caprini J; Muñoz FJ; Valle R; Monreal Bosch M;
    J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):243-50.e1. PubMed ID: 26992301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
    García-Ortega A; López-Reyes R; Anguera G; Oscullo G; Rivas A; López-Jiménez L; Lorenzo A; Mahé I; Ciammaichella M; Monreal M;
    Thromb Res; 2021 May; 201():131-138. PubMed ID: 33684796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
    Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
    Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism.
    Mellado M; Trujillo-Santos J; Bikdeli B; Jiménez D; Núñez MJ; Ellis M; Marchena PJ; Vela JR; Clara A; Moustafa F; Monreal M;
    Intern Emerg Med; 2019 Oct; 14(7):1101-1112. PubMed ID: 31054013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation.
    Fernández-Capitán C; Rodriguez Cobo A; Jiménez D; Madridano O; Ciammaichella M; Usandizaga E; Otero R; Di Micco P; Moustafa F; Monreal M;
    Res Pract Thromb Haemost; 2021 Jan; 5(1):168-178. PubMed ID: 33537541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolism.
    Trujillo-Santos J; Martos FM; Font C; Farge-Bancel D; Rosa V; Lorenzo A; Barrón M; Lorente MA; Pedrajas JM; Monreal M
    Heliyon; 2017 Jan; 3(1):e00229. PubMed ID: 28119956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.